Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
Highlights of the PCI news focused on Penn commercialization accomplishments
The company reported positive results in the first two patients who received its new CAR T therapy, CABA-201, which aims to treat the autoimmune diseases lupus and myositis.
César de la Fuente, PhD, Presidential Assistant Professor at Penn, has significantly advanced the field of antibiotic discovery through his innovative use of computational and AI-assisted techniques.
Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.
In the article, Technical.ly highlights that Penn affiliated startups attracted over $1 billion in investment capital in 2023.
ViTToria is focused on developing novel CAR-T cell therapies that transcend the limitations of current cell therapies.
Heirloom uses a process called direct air capture to remove greenhouse gases from the atmosphere.
Co-founded by Saar Gill, MD, PhD, Interius is developing a new platform for cell-specific gene delivery in patients.
The Penn Center of Innovation was recognized in an article in Clinical Leader about how academic medical centers can leverage their unique advantages to develop and deliver cell and gene therapies.
Penn graduates Alex Imbot ‘20 and Eli Moraru ‘21 were featured in the Inquirer for their non-profit corner store idea, The Community Grocer, which improves food access for those using SNAP benefits.
PitchBook released its 2023 list of the best universities for founders, and Penn ranked fourth among undergraduate schools with 1,083 founders, 993 companies and $34 billion raised.